RECORDATORIO: Nuestro equipo de la línea de atención telefónica está trabajando a distancia y centrando su tiempo en ayudar a nuestros pacientes. Agradecemos a las farmacias, a los proveedores y a su personal que utilicen nuestros Portales de Farmacia y de Proveedores. Por favor, tenga en cuenta que si se pone en contacto con nosotros sobre un pago o una subvención, es más rápido enviarnos un correo electrónico a [email protected]. Le agradecemos su paciencia y esperamos seguir sirviéndole. Les deseamos a todos seguridad y buena salud durante estos momentos difíciles. El equipo de HealthWell
Bronquiectasia
Status
ClosedThis fund is temporarily closed to new patients due to lack of sufficient funding. Please continue to visit our Disease Funds page often, as replenished funds reopen as quickly as possible. If you currently have a grant with HealthWell, your grant will remain active for the entire 12 month grant cycle or until you have exhausted your allocated grant amount, whichever comes first. You can continue to use your pharmacy card or submit requests for reimbursements during your designated grant cycle.
Assistance Type
Prescription Drug Copayor
Insurance premium (Medicare Part B only)
Maximum Award Level
Payment Type
Pharmacy CardMinimum Copay Reimbursement Amount
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
Minimum Premium Reimbursement Amount
Household Income Limit
500% of the Federal Poverty Level(adjusted for household size and high cost of living areas)
Treatments Covered
- Acetylcysteine
- Adoxa
- Amikacin
- Amikacin Sulfate
- Amoxicillin
- Amoxicillin And Clavulanic Potassium
- Amoxicillin Trihydrate
- Ampicillin And Sulbactam
- Ampicillin-sulbactam
- Augmentin
- Avidoxy
- Azactam
- Azithromycin
- Azithromycin Dihydrate
- Aztreonam
- Bethkis
- Brensocatib
- Brinsupri
- Bronchitol
- Ceftazidime
- Ceftriaxone
- Ceftriaxone Sodium
- Ceftriaxone/dextrose
- Cipro
- Ciprofloxacin
- Ciprofloxacin Hydrochloride
- Ciprofloxacin In Dextrose
- Clarithromycin
- Colistimethate Sodium
- Doxycycline
- Doxycycline Monohydrate
- E.e.s. 400
- E.e.s. Granules
- Ery-tab
- Eryped 200
- Eryped 400
- Erythromycin
- Erythromycin Ethylsuccinate
- Erythromycin Ethylsuccinate Granules
- Gentamicin Sulfate
- Isoproterenol Hcl
- Kitabis Pak
- Levofloxacin
- Levofloxacin Hemihydrate
- Linezolid
- Mannitol
- Meropenem
- Moxatag
- Oracea
- Piperacillin And Tazobactam
- Piperacillin Sodium And Tazobactam Sodium
- Rifampin
- Targadox
- Tazicef
- Tobi
- Tobi Podhaler
- Tobramycin
- Tobramycin Inhalation Solution Pak
- Tobramycin Sulfate
- Trimethoprim
- Tyzavan
- Unasyn
- Urea
- Vancomycin Hcl
- Vancomycin Hydrochloride
- Vibramycin Monohydrate
- Zithromax
- Zosyn
- Zyvox
Fund Definition
Assistance with the prescription drugs and biologics used in the treatment of Bronchiectasis.
Grant Utilization
HealthWell estimates that patients use an average of $2,500 during their 12-month grant period for this disease area.
Do I Qualify?
HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:
-
Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Diseases and Medications listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.
-
To qualify for copayment assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. Please note that in order to qualify for premium assistance through this fund, you must have Medicare Part B. The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.
-
HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
-
If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
About Bronchiectasis
Bronchiectasis is a lung disease that may begin in childhood as a result of an infection or other illness that injures the airways in the lungs. The injury or infection starts the cycle where airways slowly lose their ability to clear mucus. Mucus builds up and causes bacteria to grow, leading to repeated serious lung infections, causing more damage to airways in the lungs. Airways become scarred and stretched, resulting in the inability to move air in and out. Symptoms may not appear for months or years after the onset of repeated lung infections. Other common comorbidities include nontuberculous mycobacterial (NTM) lung disease, primary ciliary dyskinesia (PCD), and chronic obstructive pulmonary disease (COPD).
Additional Educational Resources
You may also visit our Resource List to view other copayment organizations that may provide assistance.